Gene Query: EXOSC10

Dataset Description Geneva Score
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 126.51
63.48
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 34.85
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 34.85
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 31.18
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 30.72
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 30.72
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 17.9
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 16.19
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 15.9
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 15.9
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 15.84
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 15.48
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 15.36
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 15.21
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 15.21
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 14.5
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 14.47
LNCaP treated with iBET 14.31
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 14.25
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 14.06
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 14.06
Genome wide miR-191 target profile determined by RIP and gene expression profiling 13.57
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 13.57
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 13.55
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 13.53
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  13.31
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 13.28
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.1
Differential expression of genes in AD169-infected MRC5. 12.87
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 12.61
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 12.61
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 12.53
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 12.53
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 12.39
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.34
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.34
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 12.18
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 12.01
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 12.01
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 11.69
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 11.68
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.54
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 11.54
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 11.51
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 11.46
FBXW7 modulates stress response by post-translational modification of HSF1 11.46
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 11.29
Transcriptomic analyssis following EHMT1/2 inhibition 11.16
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 10.93
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.88
RNAseq Study in CC-671 Treated Cal-51 Cells 10.84
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 10.66
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 10.25
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 9.9
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 9.88
3’ Uridylation Expands miRNA Target Repertoire 9.67
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.57
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 9.55
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 9.55
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 9.54
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 9.54
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 9.51
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 9.51
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 9.48
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 9.42
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.33
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 9.28
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.26
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.23
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 9.19
A Unique Epigenomic Landscape Defines Human Erythropoiesis 9.15
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 9.15
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.13
RNAseq of HEK293 cells after Chtop knockdown 9.13
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 9.13
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 9.11
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 9.11
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 9.09
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 9.0
LncRNA-GAS5 negative regulation of YAP-target genes expression 8.97
RNA-seq analysis of differentiating human erythroblasts 8.91
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 8.71
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 8.59
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.53
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 8.51
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 8.45
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 8.45
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 8.45
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 8.45
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.44
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.44
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 8.42
MeRIP-seq for heat shock in B-cell lymphoma cells 8.36
Genes significantly down or Up-regulated upon RNF219 knockdown 8.29
Mechanistic Model-Guided Study of Embryonic Morphogenesis 8.23
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.22
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.0
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.99
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.99
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.84
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.84
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.84
Paxillin regulates genomic networks in prostate cancer [PC3] 7.83
TCF7L1 knockdown in pancreatic cancer 7.75
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.74
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 7.67
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 7.66
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 7.65
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 7.65
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.61
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.6
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 7.59
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 7.58
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 7.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.52
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 7.49
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 7.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 7.46
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 7.43
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 7.43
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 7.42
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.38
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.38
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 7.37
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.36
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.33
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.32
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 7.31
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 7.26
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 7.24
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 7.24
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.22
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 7.13
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 7.13
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 7.11
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.06
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 7.02
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 7.02
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.01
Systematic discovery of endogenous human ribonucleoprotein complexes 6.94
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.93
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.87
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.86
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.85
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 6.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 6.8
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.77
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.77
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 6.77
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 6.76
Human embryonic stem cells in E8 and AKIT culture medium 6.76
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.7
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 6.63
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.63
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.59
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 6.59
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 6.56
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 6.56
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 6.56
MYC dependent mRNA translation shapes gene expression and cell biology 6.54
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.49
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 6.49
NHLRC1 re-expression in cancer cells 6.48
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 6.45
K562 polyA RNA-Seq 6.44
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 6.43
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 6.38
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 6.36
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 6.35
Trans-differentiation of human adult peripheral blood T cells into neurons 6.31
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 6.3
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 6.3
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.29
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 6.28
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 6.28
Total RNA-seq in ALL-SIL upon JQ1 inhibition 6.27
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 6.26
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 6.25
A549 cells and MSR-A549 cells 6.24
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.24
Maturation of human iNSCs 6.22
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 6.18
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.17
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.16
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 6.14
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.13
Transcriptome of U251 cells overexpression complement component 7 6.12
Transcriptome analysis of BAP1 knockout and restoration 6.04
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 6.04
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 6.03
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 6.03
G-quadruplex structures mark human regulatory chromatin 6.0
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.0
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.0
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.97
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.97
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 5.93
Knockdown of ADNP in HCT116 colon cancer cells 5.92
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.86
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 5.83
Transcriptomic analysis of the HOTAIR-regulated genes 5.77
R430: A potent inbibitor of DNA and RNA viruses 5.75
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.74
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 5.74
Transcriptional profiling of LS1034 cells treated with tepoxalin 5.74
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 5.65
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.64
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 5.63
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.6
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.59
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.59
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.55
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.53
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 5.53
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 5.53
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.52
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.46
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.46
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.44
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 5.41
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 5.36
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 5.36
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.36
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.35
Differetially expressed genes after hTR overexpression in U2OS cells 5.34
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.33
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 5.29
RNA-seq of YB5 cells treated with Proscillaridin A 5.29
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 5.28
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.22
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.22
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.18
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.18
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.18
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.18
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.17
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.14
Regulation of protein translation during mitosis 5.14
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.09
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.04
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.02
Gene expression profile in breast cancer cells 5.02
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.01
METTL3 and WTAP 4.97
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.91
High-throughput sequencing of pluripotent cells 4.9
Transcriptomic analysis of human tonsillar TFH subsets 4.88
Landscape and variation of RNA secondary structure across the human transcriptome 4.88
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.88
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 4.86
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.79
LIN28A Over-expression RNAseq 4.76
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 4.75
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.73
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.72
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.62
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.6
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.6
Functional role of CPPED1 in trophoblasts. 4.55
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 4.52
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 4.52
Biological effect of chronic mistranslation in mammalian cells 4.5
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.49
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 4.46
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 4.46
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 4.4
SRSF1 role in cellular gene expression and splicing 4.36
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.34
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 4.34
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.33
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.32
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.31
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 4.28
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.25
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 4.23
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 4.23
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.17
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.17
SLIGRL-induced gene expression changes in NHEK cells 4.16
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 4.15
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.11
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.09
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.06
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.05
RNA-seq of naive and primed ES cells 4.04
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.02
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.99
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.91
Transcriptome analysis upon C6orf203 silencing 3.88
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.87
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.83
Expression data from miR340 overexpressing human A549 cells 3.82
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.74
Effect of CHKA knockdown on C4-2 cell transcriptome 3.72
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.71
Capturing the Interactome of Newly Transcribed RNA 3.71
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.67
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.66
Ribosome profiling upon inhibition of eIF4A 3.66
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.64
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 3.62
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.61
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.61
RNA sequencing of primary human platelets and in vitro cell lines 3.58
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 3.49
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 3.49
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.48
Dysregulated immune system networks in war veterans with PTSD 3.47
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.45
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.45
A novel target of EZH1/2 for treatment of mantle cell lymphoma 3.4
Molecular Criteria for Defining the Naive Human Pluripotent State 3.37
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.37
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.37
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 3.35
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.27
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 3.24
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.24
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 3.24
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.21
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.21
Genome-wide discovery of human splicing branchpoints [RNAse] 3.18
Human Treg NaCl stimulation 3.18
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.18
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.17
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.12
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.1
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.1
Mapping interactions for the TNIP2 hub protein 3.09
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.06
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.05
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.04
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.0
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.0
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.98
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.98
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 2.92
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.91
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.9
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.88
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.85
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.83
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.81
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.8
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.79
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.76
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 2.74
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.73
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 2.7
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.68
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.68
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.64
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.63
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.63
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.61
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.6
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.59
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.59
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.55
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.55
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.51
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.48
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.47
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.43
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.4
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.38
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.37
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.37
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.36
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.32
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.31
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.2
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.2
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.19
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.19
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 2.17
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.11
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.1
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 2.09
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.08
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 2.07
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.07
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.07
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.06
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.06
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.05
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.05
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.01
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.01
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.01
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.95
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.95
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.95
Transposon-based construction of strand-specific RNA-seq libraries 1.87
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.84
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.84
O-glcnAc reprograms cellular energetics 1.69
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.65
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.65
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.65
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.62
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 1.59
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.57
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.56
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.54
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.5
Solid phase chemistry to covalently and reversibly capture thiolated RNA 1.49
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.49
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.41
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.41
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.39
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 1.38
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.38
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.38
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.37
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.3
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.3
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.27
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.23
Transcriptome sequencing of K-562 cells 1.2
Ribosomal protein RPL26 is the principal target of UFMylation 1.2
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.19
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.17
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.09
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.08
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.08
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.04
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.04
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.04
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.03
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.03
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.02
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.01
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.01
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.0
The role of m6A/m-RNA methylation in stress response regulation 1.0
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.97
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.97
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.87
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.85
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.84
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.77
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.75
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.73
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.68
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.68
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.66
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.66
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.62
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.62
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.58
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.56
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 0.49
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.48
Aging-associated patterns in the expression of human endogenous retroviruses 0.46
Transcriptome-wide response to synthetic chromatin protein PcTF 0.46
RNA-seq data 0.45
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.44
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.43
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.43
Gene expression changes due to PARP knockdown in human cells 0.42
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.41
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.39
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.34
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.31
Myc activation coordinates gene transcription and protein translation responses 0.27
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.24
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.24
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.23
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.23
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.21
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.21
Human Treg IL-12 stimulation 0.18
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.17
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.16
High-resolution comparative analysis of great ape genomes 0.13
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.13
p53 activity results in DNA replication fork processivity 0.13
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.13
The bromodomain protein BRD4 regulates splicing during heat shock 0.12
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.1
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.1
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.1
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.07
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.07
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.06
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.05
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.04
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.04
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.03
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.02
Determining mRNA half-lives on a transcriptome-wide scale 0.0
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.0
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation